FDA approves Ferriprox to treat transfusional iron overload due to sickle cell disease May 3, 2021 No Comments
Hillhurst cleared by FDA to begin phase I study of HBI-002 for sickle cell disease April 28, 2021 No Comments
Fulcrum Therapeutics' FTX-6058 could be a disease-modifying treatment for sickle cell disease April 26, 2021 No Comments
Enrollment ongoing in phase I/II study of EXG-34217 in patients with bone marrow failure April 15, 2021 No Comments
Biotest adds additional patient group to ongoing phase III AdFIrst study of BT-524 April 8, 2021 No Comments
FDA clears initiation of first-in-human study of CRISPR_SCD-001 for sickle cell disease March 31, 2021 No Comments
RSS